A Pilot Study of the Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03156634|
Recruitment Status : Completed
First Posted : May 17, 2017
Last Update Posted : April 23, 2019
|Condition or disease||Intervention/treatment||Phase|
|Patient Education||Other: PALS Other: WebMD||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||118 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Participants will be randomized to view materials via one of to systems (Patient Activated Learning System or WebMD)|
|Masking:||Single (Outcomes Assessor)|
|Masking Description:||The statistician will be masked to the group assignment.|
|Primary Purpose:||Health Services Research|
|Official Title:||The Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making About Antihypertensive Medication: A Pilot Study|
|Actual Study Start Date :||April 15, 2017|
|Actual Primary Completion Date :||December 31, 2017|
|Actual Study Completion Date :||December 31, 2017|
Participants will view materials about the antihypertensive, chlorthalidone on the Patient Activated Learning System (PALS).
PALS is a web based patient education system that uses text and audiovisual formats to deliver patient education materials.
Active Comparator: WedMD
Participants will view materials about the antihypertensive, chlorthalidone on WebMD.
WebMD is an internet based health information source.
- Knowledge acquisition [ Time Frame: Immediate ]Subjects will be asked questions about the materials they viewed.
- Recall [ Time Frame: 1 week ]Subjects will be asked questions about the materials they viewed.
- User experience [ Time Frame: Immediate ]Participants will be asked about user experience including trust, usefulness, comprehensibility, and adequacy of the information, attractiveness of the site, and level of engagement of materials.
- Decision making [ Time Frame: Immediate ]Participants will be asked if they have sufficient information to make hypothetical decisions about taking chlorthalidone.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03156634
|United States, New York|
|Weill Cornell Internal Medicine Associates|
|New York, New York, United States, 10021|
|Principal Investigator:||Amanda S Carmel, MD||Weill Medical College of Cornell University|